Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Thiamine Supplementation in Hemodialysis Patients with Mild Cognitive Impairment
TCTR20251212005Phase 3Recruiting
- Sponsor
- The Kidney Foundation of Thailand
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thiamine in Mild Cognitive Impairment (MCI), sponsored by The Kidney Foundation of Thailand. Started Sep 2025; status: recruiting.
02
Drugs
thiamine
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on TCTR20251212005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251212005.